From: Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers
IHC parameter
Cases vs controls // primary vs metastatic lesions (%)
N
Mean (%)
Median (%)
Range
pValue
AR
Cases
39
14.15
5
0–70
<  0.001
Controls
40
42.05
37.5
0–95
Primary tumor
24
12.70
2.5
0.270
Brain metastasis
9.25
0
0–60